DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Exparel 266 mg/20 ml vials. The $7,464.33 order was awarded on October 25, 2023 and is to be completed by November 16, 2023. The contract vehicle, held by DMS Pharmaceutical Group until December 2025, provides pharmaceutical items and medical supplies to military treatment facilities supported by the Defense Logistics Agency worldwide with a potential value of up to $5 million. As a woman-owned small business, DMS Pharmaceutical Group will fulfill this delivery order through direct supply to DLA Troop Support Medical locations.
Generated 1/24/24, 10:04 AM